186 related articles for article (PubMed ID: 34037749)
1. Endothelial Insulin Receptors Promote VEGF-A Signaling via ERK1/2 and Sprouting Angiogenesis.
Walker AMN; Warmke N; Mercer B; Watt NT; Mughal R; Smith J; Galloway S; Haywood NJ; Soomro T; Griffin KJ; Wheatcroft SB; Yuldasheva NY; Beech DJ; Carmeliet P; Kearney MT; Cubbon RM
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 34037749
[TBL] [Abstract][Full Text] [Related]
2. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
[TBL] [Abstract][Full Text] [Related]
3. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J
Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828
[TBL] [Abstract][Full Text] [Related]
4. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
5. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.
Yoshida S; Aihara K; Ikeda Y; Sumitomo-Ueda Y; Uemoto R; Ishikawa K; Ise T; Yagi S; Iwase T; Mouri Y; Sakari M; Matsumoto T; Takeyama K; Akaike M; Matsumoto M; Sata M; Walsh K; Kato S; Matsumoto T
Circulation; 2013 Jul; 128(1):60-71. PubMed ID: 23723256
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
8. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
[TBL] [Abstract][Full Text] [Related]
9. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
10. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside diphosphate kinase B regulates angiogenesis through modulation of vascular endothelial growth factor receptor type 2 and endothelial adherens junction proteins.
Feng Y; Gross S; Wolf NM; Butenschön VM; Qiu Y; Devraj K; Liebner S; Kroll J; Skolnik EY; Hammes HP; Wieland T
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2292-300. PubMed ID: 25147336
[TBL] [Abstract][Full Text] [Related]
12. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase.
Stahmann N; Woods A; Spengler K; Heslegrave A; Bauer R; Krause S; Viollet B; Carling D; Heller R
J Biol Chem; 2010 Apr; 285(14):10638-52. PubMed ID: 20129920
[TBL] [Abstract][Full Text] [Related]
14. Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.
Garg J; Feng YX; Jansen SR; Friedrich J; Lezoualc'h F; Schmidt M; Wieland T
Oncotarget; 2017 Jul; 8(27):44732-44748. PubMed ID: 28512254
[TBL] [Abstract][Full Text] [Related]
15. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
Cho HD; Moon KD; Park KH; Lee YS; Seo KI
Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
[TBL] [Abstract][Full Text] [Related]
16. VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis.
Chamorro-Jorganes A; Lee MY; Araldi E; Landskroner-Eiger S; Fernández-Fuertes M; Sahraei M; Quiles Del Rey M; van Solingen C; Yu J; Fernández-Hernando C; Sessa WC; Suárez Y
Circ Res; 2016 Jan; 118(1):38-47. PubMed ID: 26472816
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
[TBL] [Abstract][Full Text] [Related]
18. Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway.
Tang N; Shi L; Yu Z; Dong P; Wang C; Huo X; Zhang B; Huang S; Deng S; Liu K; Ma T; Wang X; Wu L; Ma XC
Oncotarget; 2016 Jan; 7(3):3533-47. PubMed ID: 26657289
[TBL] [Abstract][Full Text] [Related]
19. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
